Your friend nailed it. I'm a PharmD who worked in both settings before moving to clinical practice. A few things I'd add: 1. 503A pharmacies are governed by their state board of pharmacy. This means quality standards can vary WILDLY from state to state. Some states (like Texas and Ohio) have very rigorous sterile compounding regulations. Others... not so much. 2. 503B facilities must follow current Good Manufacturing Practices (cGMP), which is the same standard applied to traditional pharmaceutical manufacturers. This includes: - Environmental monitoring programs - Media fill testing - Equipment validation - Batch record documentation - Stability testing 3. The key regulatory nuance: 503A pharmacies compound under a specific exemption from the FD&C Act (Section 503A). If they violate the conditions of that exemption — like compounding in bulk without prescriptions, or using ingredients not on the FDA's approved list — they lose that protection and are treated as an unapproved drug manufacturer. The NECC disaster in 2012 (fungal meningitis outbreak, 76 deaths) is precisely what led to the creation of the 503B pathway under the DQSA of 2013. Before that, there was a massive regulatory gap.

This is super helpful. So when I order from my telehealth provider and they ship me compounded sema, is that coming from a 503A or 503B? I asked my provider and they just said "FDA-registered compounding pharmacy" which I now realize means 503B. But I want to verify — is there a way to check?

Yes! You can verify 503B registration on the FDA's website: FDA Registered Outsourcing Facilities list: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities It's a searchable database. Look for the pharmacy name and confirm their registration status. The list also shows whether they've had any adverse event reports. For 503A pharmacies, you'd check with the relevant state board of pharmacy. Every state board maintains a license lookup tool. If your provider says "FDA-registered" they should be on that 503B list. If they're NOT on the list, that's a red flag and I'd push back hard.

Great thread. One thing that gets overlooked: the 503A loophole. Some 503A pharmacies are shipping compounded GLP-1s across state lines in significant volumes, essentially operating like a 503B without the federal oversight. This is technically illegal — 503A pharmacies are generally limited to dispensing within their state (or states where they hold a non-resident pharmacy license), and they need individual prescriptions. The enforcement has been inconsistent, which is part of the problem. The FDA has sent warning letters to some of these operations but doesn't have the resources to go after all of them. My advice: if you're getting compounded sema shipped from a pharmacy in a different state, make sure they hold a non-resident pharmacy license in YOUR state and that you have a legitimate prescription on file.